Based on our recent work, the long GnRH agonist protocol is associated with significantly higher levels of FF PlGF compared to the flexible GnRH antagonist one both; in PCOS and normo-ovulatory women [27,28]. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.